More Evidence of Fraud on Health Care In recent years drug companies have been prime targets of federal fraud investigations which have recovered billions of dollars for Medicaid and Medicare.
The British pharmaceutical company GlaxoSmithKline has agreed to pay $3 billion to the government to settle civil and criminal investigations into its sales practices for numerous drugs. The amount of the settlement is a new record surpassing the $2.3 billion paid by Pfizer in 2009.
According to prosecutors the company paid doctors and manipulated medical research to promote Avandia, a diabetic drug which was linked to heart risks.
It is heartening to know that something is being done about this problem, but seeing that the government has already recovered tens of billions of dollars, one can only wonder how much undiscovered fraud has cost the federal health care systems.
Category: Defective Product Liability
To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."